Search Results - "Brouwers, JRBJ"

Refine Results
  1. 1

    Skin disorders in chronic psychiatric illness by Mookhoek, EJ, Van De Kerkhof, PCM, Hovens, JEJM, Brouwers, JRBJ, Loonen, AJM

    “…Background  Chronic psychiatric patients are prone to develop skin diseases. However, epidemiological data are scarce. Objective  To describe the prevalence of…”
    Get full text
    Journal Article
  2. 2

    Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume by Vu, D.H., Koster, R.A., Alffenaar, J.W.C., Brouwers, J.R.B.J., Uges, D.R.A.

    “…Moxifloxacin (MFX) is a potential oral agent use in the treatment of multidrug-resistance tuberculosis (MDR-TB). Due to variability in pharmacokinetics and in…”
    Get full text
    Journal Article
  3. 3

    Treatment of Chronic Pain in Older People: Evidence-Based Choice of Strong-Acting Opioids by VAN OJIK, Annette L, JANSEN, Paul A. F, BROUWERS, Jacobus R. B. J, VAN ROON, Eric N

    Published in Drugs & aging (01-08-2012)
    “…In the treatment of chronic malignant and non-malignant pain, opioids are used as strong analgesics. Frail elderly patients often have multiple co-morbidities…”
    Get full text
    Journal Article
  4. 4

    Clinical relevance of drug-drug interactions : A structured assessment procedure by VAN ROON, Eric N, FLIKWEERT, Sander, LE COMTE, Marianne, LANGENDIJK, Pim N. J, KWEE-ZUIDERWIJK, Wilma J. M, SMITS, Paul, BROUWERS, Jacobus R. B. J

    Published in Drug safety (01-01-2005)
    “…Computerised drug interaction surveillance systems (CIS) may be helpful in detecting clinically significant drug interactions. Experience with CIS reveals that…”
    Get full text
    Journal Article
  5. 5

    Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? by Rijcken, Claudia A W, Monster, Taco B M, Brouwers, Jacobus R B J, de Jong-van den Berg, Lolkje T W

    Published in Journal of clinical psychopharmacology (01-12-2003)
    “…Classic chlorpromazine (CPZ) equivalents can be used to chart relative antipsychotic potencies of antipsychotic drugs. Values of CPZ equivalents per drug are…”
    Get full text
    Journal Article
  6. 6

    Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam by Vu, D. H., van Rein, N., Cobelens, F. G. J., Nguyen, T. T. H., Le, V. H., Brouwers, J. R. B. J.

    “…SETTINGS: Private pharmacies in Hanoi, Viet Nam.OBJECTIVES: To explore the response of health care providers (HCPs) in private pharmacies to suspected…”
    Get full text
    Journal Article
  7. 7

    Frequency and determinants of drug administration errors in the intensive care unit by van den Bemt, Patricia M. L. A, Fijn, Roel, van der Voort, Peter H. J, Gossen, Annet A, Egberts, Toine C. G, Brouwers, Jacobus R. B. J

    Published in Critical care medicine (01-04-2002)
    “…OBJECTIVE The study aimed to identify both the frequency and the determinants of drug administration errors in the intensive care unit. DESIGN Administration…”
    Get full text
    Journal Article
  8. 8

    Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia by Al Hadithy, A.F.Y., Ivanova, S.A., Pechlivanoglou, P., Semke, A., Fedorenko, O., Kornetova, E., Ryadovaya, L., Brouwers, J.R.B.J., Wilffert, B., Bruggeman, R., Loonen, A.J.M.

    “…Pharmacogenetics of tardive dyskinesia and dopamine D3 (DRD3), serotonin 2A (HTR2A), and 2C (HTR2C) receptors has been examined in various populations, but not…”
    Get full text
    Journal Article
  9. 9

    Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients by Reinders, Mattheus K, van Roon, Eric N, Houtman, Pieternella M, Brouwers, Jacobus R B J, Jansen, Tim L Th A

    Published in Clinical rheumatology (01-09-2007)
    “…In 2003, the uricosuric drug benzbromarone was withdrawn from the market. The first alternative drug of choice was the xanthine oxidase inhibitor allopurinol…”
    Get full text
    Journal Article
  10. 10

    Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations by Al Hadithy, A.F.Y., de Boer, N.K.H., Derijks, L.J.J., Escher, J.C., Mulder, C.J.J., Brouwers, J.R.B.J.

    Published in Digestive and liver disease (01-04-2005)
    “…There is a growing interest in the use of thiopurines (azathioprine, 6-mercaptopurine and 6-thioguanine) for the management of inflammatory bowel disease. The…”
    Get full text
    Journal Article
  11. 11

    Meta‐analysis: comparing the efficacy of proton pump inhibitors in short‐term use by Klok, R. M., Postma, M. J., Van Hout, B. A., Brouwers, J. R. B. J.

    Published in Alimentary pharmacology & therapeutics (15-05-2003)
    “…Summary Background:  Proton pump inhibitors have a prominent role in the management of acid‐related diseases. Controlling expenses on proton pump inhibitors…”
    Get full text
    Journal Article
  12. 12

    Drug-related problems in hospitalised patients by VAN DEN BEMT, P. M. L. A, EGBERTS, T. C. G, DE JONG-VAN DEN BERG, L. T. W, BROUWERS, J. R. B. J

    Published in Drug safety (01-04-2000)
    “…Drug-related problems include medication errors (involving an error in the process of prescribing, dispensing, or administering a drug, whether there are…”
    Get full text
    Journal Article
  13. 13

    Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis by van Roon, E N, Jansen, T L T A, van de Laar, M A F J, Janssen, M, Yska, J P, Keuper, R, Houtman, P M, Brouwers, J R B J

    Published in Annals of the rheumatic diseases (01-04-2005)
    “…Background: Leflunomide is the prodrug of the disease modifying antirheumatic metabolite A77 1726. More than 50% of patients withdraw from leflunomide…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Substantial skin disorders in psychiatric illness coincide with diabetes and addiction by Mookhoek, EJ, van de Kerkhof, PCM, Hovens, JEJM, Brouwers, JRBJ, Loonen, AJM

    “…Background  Dermatological diseases in psychiatric patients are common; however, epidemiological data on this subject are scarce and to our knowledge integral…”
    Get full text
    Journal Article
  16. 16

    Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs by VONKEMAN, Harald E, KLOK, Rogier M, POSTMA, Maarten J, BROUWERS, Jacobus R. B. J, VAN DE LAAR, Mart A. F. J

    Published in Drugs & aging (01-01-2007)
    “…The occurrence and prevention of gastrointestinal ulcers during use of NSAIDs has become a major healthcare issue. To determine the direct medical costs of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Hospital prescribing errors: epidemiological assessment of predictors by Fijn, R., Van den Bemt, P. M. L. A., Chow, M, De Blaey, C. J., De Jong‐Van den Berg, L. T. W., Brouwers, J. R. B. J.

    Published in British journal of clinical pharmacology (01-03-2002)
    “…Aims  To demonstrate an epidemiological method to assess predictors of prescribing errors. Methods  A retrospective case‐control study, comparing prescriptions…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands by Jansman, Frank G.A, Postma, Maarten J, van Hartskamp, David, Willemse, Pax H.B, Brouwers, Jacobus R.B.J

    Published in Clinical therapeutics (01-04-2004)
    “…Background: Capecitabine is an oral prodrug of 5-fluorouracil and has been studied for the treatment of colorectal cancer. In 2 Phase III trials, capecitabine…”
    Get full text
    Journal Article